Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Varespladib (LY315920) neutralises phospholipase A2 mediated prothrombinase-inhibition induced by Bitis snake venoms
Nicholas J. Youngman, Andrew A. Walker, Arno Naude, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2020) Vol. 236, pp. 108818-108818
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Haemotoxicity of snakes: a review of pathogenesis, clinical manifestations, novel diagnostics and challenges in management
Bhawani Yasassri Alvitigala, Harsha Dissanayake, Praveen Weeratunga, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2025)
Open Access | Times Cited: 2
The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
José Marı́a Gutiérrez, Laura-Oana Albulescu, Rachel H. Clare, et al.
Toxins (2021) Vol. 13, Iss. 7, pp. 451-451
Open Access | Times Cited: 67
Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes
Matthew R. Lewin, Rebecca W. Carter, Isabel A. Matteo, et al.
Toxins (2022) Vol. 14, Iss. 11, pp. 783-783
Open Access | Times Cited: 47
Varespladib Inhibits the Phospholipase A2 and Coagulopathic Activities of Venom Components from Hemotoxic Snakes
Chunfang Xie, Laura-Oana Albulescu, Kristina B. M. Still, et al.
Biomedicines (2020) Vol. 8, Iss. 6, pp. 165-165
Open Access | Times Cited: 51
High-throughput proteomics and in vitro functional characterization of the 26 medically most important elapids and vipers from sub-Saharan Africa
Giang Thi Tuyet Nguyen, Carol O’Brien, Yessica Wouters, et al.
GigaScience (2022) Vol. 11
Open Access | Times Cited: 26
In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus
Stefanie K. Menzies, Rachel H. Clare, Chunfang Xie, et al.
Toxicon X (2022) Vol. 14, pp. 100118-100118
Open Access | Times Cited: 21
In Vitro Efficacy of Antivenom and Varespladib in Neutralising Chinese Russell’s Viper (Daboia siamensis) Venom Toxicity
Mimi Lay, Qing Liang, Geoffrey K. Isbister, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 62-62
Open Access | Times Cited: 12
Children and Snakebite: Snake Venom Effects on Adult and Paediatric Plasma
Christina N. Zdenek, Caroline Fabri Bittencourt Rodrigues, Lachlan A. Bourke, et al.
Toxins (2023) Vol. 15, Iss. 2, pp. 158-158
Open Access | Times Cited: 11
Electrical Cell Impedance Sensing (ECIS): Feasibility of a Novel In Vitro Approach to Studying Venom Toxicity and Potential Therapeutics
Aniruddha Choudhury, Kaitlin Linne, Tommaso C. Bulfone, et al.
Toxins (2025) Vol. 17, Iss. 4, pp. 193-193
Open Access
Snake venom proteome of Protobothrops mucrosquamatus in Taiwan: Delaying venom-induced lethality in a rodent model by inhibition of phospholipase A2 activity with varespladib
Chien-Chun Liu, Cho-Ju Wu, Yen-Chang Hsiao, et al.
Journal of Proteomics (2020) Vol. 234, pp. 104084-104084
Closed Access | Times Cited: 29
Clinical implications of differential procoagulant toxicity of the palearctic viperid genus Macrovipera, and the relative neutralization efficacy of antivenoms and enzyme inhibitors
Abhinandan Chowdhury, Christina N. Zdenek, James Dobson, et al.
Toxicology Letters (2021) Vol. 340, pp. 77-88
Closed Access | Times Cited: 27
The synthetic varespladib molecule is a multi-functional inhibitor for PLA2 and PLA2-like ophidic toxins
Daniela P. Marchi‐Salvador, Rafael J. Borges, Bruno Lomonte, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1865, Iss. 7, pp. 129913-129913
Closed Access | Times Cited: 26
Anticoagulant Activity of Naja nigricollis Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
Taline D. Kazandjian, Arif Arrahman, Kristina B. M. Still, et al.
Toxins (2021) Vol. 13, Iss. 5, pp. 302-302
Open Access | Times Cited: 24
Enhancing Snakebite Management: The Role of Small Molecule Therapeutics in Complementing Antivenom Strategies
Grasiela Mariano Silva, Abhinandan Chowdhury
Toxicon (2024) Vol. 249, pp. 108081-108081
Closed Access | Times Cited: 3
Anticoagulant Micrurus venoms: Targets and neutralization
Daniel Dashevsky, Melisa Bénard-Valle, Édgar Neri-Castro, et al.
Toxicology Letters (2020) Vol. 337, pp. 91-97
Closed Access | Times Cited: 26
The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (Naja Species) Venoms
Abhinandan Chowdhury, Matthew R. Lewin, Christina N. Zdenek, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 23
Advances in the Therapeutic Application of Small-Molecule Inhibitors and Repurposed Drugs against Snakebite
Upasana Puzari, Pedro Alexandrino Fernandes, Ashis K. Mukherjee
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 19, pp. 13938-13979
Closed Access | Times Cited: 20
Action of Varespladib (LY-315920), a Phospholipase A2 Inhibitor, on the Enzymatic, Coagulant and Haemorrhagic Activities of Lachesis muta rhombeata (South-American Bushmaster) Venom
Pamella G. Gutierres, Diego Roberto Pereira, Nataly L. Vieira, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 13
In vivo treatment with varespladib, a phospholipase A2 inhibitor, prevents the peripheral neurotoxicity and systemic disorders induced by Micrurus corallinus (coral snake) venom in rats
Rosimeire Silva-Carvalho, Matheus Z. Gaspar, Luiz H.B. Quadros, et al.
Toxicology Letters (2021) Vol. 356, pp. 54-63
Open Access | Times Cited: 17
Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling
Cara F. Smith, Cassandra M. Modahl, David Ceja-Galindo, et al.
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 6, pp. 100779-100779
Open Access | Times Cited: 2
Anticoagulant activity in Australasian elapid snake venoms and neutralisation with antivenom and varespladib
Kate Murphy, Theo Tasoulis, Nathan Dunstan, et al.
Toxicon (2024) Vol. 247, pp. 107836-107836
Open Access | Times Cited: 2
Extreme Procoagulant Potency in Human Plasma of Venoms from the African Viperid Genera Atheris, Cerastes, and Proatheris and the Relative Efficacy of Antivenoms and Synthetic Enzyme-Inhibitors
Abhinandan Chowdhury, Matthew R. Lewin, Rebecca W. Carter, et al.
Toxins (2022) Vol. 14, Iss. 12, pp. 836-836
Open Access | Times Cited: 10
Widespread and Differential Neurotoxicity in Venoms from the Bitis Genus of Viperid Snakes
Nicholas J. Youngman, Richard J. Harris, Tam M. Huynh, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 3, pp. 697-704
Closed Access | Times Cited: 14
Efficacy and Limitations of Chemically Diverse Small-Molecule Enzyme-Inhibitors against the Synergistic Coagulotoxic Activities of Bitis Viper Venoms
Nicholas J. Youngman, Matthew R. Lewin, Rebecca Carter, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1733-1733
Open Access | Times Cited: 9
Utilising venom activity to infer dietary composition of the Kenyan horned viper (Bitis worthingtoni)
Nicholas J. Youngman, Abhinandan Chowdhury, Christina N. Zdenek, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2020) Vol. 240, pp. 108921-108921
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top